• Profile
Close

Evaluation of effectiveness and safety of a herbal compound in primary insomnia symptoms and sleep disturbances not related to medical or psychiatric causes

Nature and Science of Sleep Aug 18, 2017

Palmieri G, et al. – This study contemplated the safety and effectiveness of a herbal compound composed of valerian, hop, and jujube (Vagonotte) on primary insomnia symptoms and sleep disturbances not associated with medical or psychiatric causes. It was reported that the botanicals dietary supplement with relaxing and soothing properties could assist the practitioner in treating primary insomnia, especially when the risk/benefit profile of a patient did not sustain hypnotic drugs prescription. It brought to light fascinating perspectives on the utility of herbal compound to manage primary insomnia. In order to comprehend the herbal compounds’ effectiveness on sleep disturbances, additional analyses were warranted.

Methods

  • 120 enrollees with sleep disturbances symptoms were randomized in two branches of 60 persons each, receiving the herbal compound or placebo at dosage of two pills per day 30 minutes before their scheduled bedtime.
  • They were screened for precise items associated with sleep quality and daytime activity at the beginning, after 10 days, and after 20 days of consecutive dietary supplement (or placebo) consumption.
  • The candidates remained blind to group assignment until all of them completed the trial.

Results

  • Analysis was carried out of the sleep onset, numbers of nocturnal awakenings, and overall nocturnal slept time.
  • A statistically significant change was noted between the two groups.
  • The group receiving the herbal compound reported a lower time of sleep onset compared to placebo group.
  • Similar findings were seen for total slept time and night awakenings frequency (p<0.001).
  • Daily symptom improvement in subjects receiving the herbal compound exhibited a marked reduction in tension and irritability, difficulty in concentration, and fatigue intensity if compared to placebo scores (p<0.001).
  • The subjects in the verum group did not report adverse reaction related to the herbal compound.
  • 98% of the participants judged the product as displaying from good to excellent safety and tolerability.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay